There won’t be enough Covid-19 vaccines till 2024, says SII CEO

There won’t be enough Covid-19 vaccines till 2024, says SII CEO
NEW DELHI, SEP 14 (AGENCIES) | Publish Date: 9/14/2020 12:44:45 PM IST

Serum Institute of India’s (SII) CEO Adar Poonawalla has warned there won’t be enough Covid-19 vaccines available in the world till 2024 at the earliest, according to a media report on Monday. “It’s going to take four to five years until everyone gets the vaccine on this planet,” said Poonawalla to Financial Times. The CEO of the world’s largest vaccine manufacturer has estimated that if the Covid-19 shot is a two-dose vaccine— such as measles or rotavirus — the world will need 15 billion doses, reported FT.

The Pune-based pharma giant has partnered with five international pharmaceutical firms, including AstraZeneca and Novavax, to develop a Covid-19 vaccine and committed to producing one billion doses, of which it has pledged half to India. Moreover, SII may also partner with Russia’s Gamaleya Research Institute to manufacture the Sputnik vaccine.

He said that the commitment far exceeded the capacity of other vaccine producers. “I know the world wants to be optimistic on it . . . [but] I have not heard of anyone coming even close to that [level] right now,” he told FT.

Poonawalla’s comments come just a day after India’s Health Minister Harsh Vardhan said that while there has been no date fixed on the availability of a potential Covid-19 vaccine, chances are it may be ready by the first quarter of 2021. He assured the vaccine will be first made available to those who need it the most, irrespective of their paying capacity.

“Issues like vaccine security, cost, equity, cold-chain requirements, production timelines etc., are also been discussed intensely,” he stated. On the availability of the vaccine and its authorization, Vardhan informed that Centre is considering emergency authorization of COVID-19 vaccination especially in the case of senior citizens and people working in high-risk settings. “This shall be done after a consensus has been reached”, he said, according to an official statement. To allay fears regarding the safety aspect of the vaccines, he said, “I shall be the first to offer myself for receiving COVID vaccine, if people have a trust deficit.”

Furthermore, the Financial Times also reported that as part of SII’s agreement with AstraZeneca, the firm will aim to produce vaccine doses that cost around $3 for 68 countries and under its agreement with Novavax, for 92 countries.

-Tags:#SII CEO

Launched on December 3,1990. Nagaland Post is the first and highest circulated newspaper of Nagaland state. Nagaland Post is also the first newspaper in Nagaland to be published in multi-colour.

Desk:+91-3862-248 489, e-mail: Fax: +91-3862-248 500
Advt.:+91-3862-248 267,



Join us on

© Nagaland Post 2018. All Rights are Reserved
Designed by : 4C Plus